Primary record
(1S)-3-[(1E)-2-[(1R,3aR,7aR)-1-[(1R)-1,5-dimethylhexyl]-2,3,3a,6,7,7a-hexahydro-7a-methyl-1H-inden-4-yl]ethenyl]-4-methyl-3-cyclohexen-1-ol; 9,10-Secocholesta-5(10),6,8-trien-3-ol, (3ss,6E)- (9CI); Tachysterol3 (6CI,7CI,8CI)
- 库存
- 9,552 克
- 纯度
- 99.2 %
- CAS
- 17592-07-3
化合物标识与属性
- CAS
- 17592-07-3
- PubChem CID
- 5283713
- SMILES
- CC1=C(C[C@H](CC1)O)/C=C/C2=CCC[C@]3([C@H]2CC[C@@H]3[C@H](C)CCCC(C)C)C
- Canonical SMILES
- CC1=C(/C=C/C2=CCC[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@H]23)C[C@@H](O)CC1
名称与同义词
- Tachysterol 3
- tachysterol3
- tacalciol
- tachysterol_3
- Previtamin D(3)
- 17592-07-3
- (6E)-tacalciol
- Cholecalciferol EP Impurity E
- 6RR0I9PK8W
- Tachysterol3 (80%)
- UNII-6RR0I9PK8W
- AC1NR2UX
- Cholecalciferol Impurity E
- RefChem:1099364
- UNII-HDA46400N5
- C27H44O
- CHEBI:166835
- 1H-Indole,4-methoxy-6-nitro
- DTXSID301317912
- SCHEMBL4983742
- (3beta,6E)-9,10-Secocholesta-5(10),6,8-trien-3-ol
- EINECS 241-561-3
- YUGCAAVRZWBXEQ-FMCTZRJNSA-N
- DTXCID901747707
- ZINC5766454
- EINECS 214-634-2
- C27-H44-O
- LMST03020223
- MFCD32701931
- AKOS040757010
- CID5283713
- HY-130705A
- (6E)-(3S)-9,10-seco-5(10),6,8-cholestatrien-3-ol
- DA-58241
- FT159098
- J13.964E
- MS-26337
- CS-0111457
- CHOLECALCIFEROL IMPURITY E [EP IMPURITY]
- (3S,6E)-9,10-secocholesta-5(10),6,8-trien-3-ol
- (6E)-9,10-secocholesta-5(10),6,8-trien-3beta-ol
- F554678
- (1S)-3-[(E)-2-[(1R,3aR,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-1,2,3,3a,6,7-hexahydroinden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol
- (3beta,6Z)-9,10-Secocholesta-5(10),6,8-trien-3-ol
- A1002812
- Q27265389
- (3?,6E)-9,10-secocholesta-5(10),6,8-trien-3-ol
- (3b,6E)-9,10-Secocholesta-5(10),6,8-trien-3-ol
- (6E)-9,10-Secocholesta-5(10),6,8-trien-3beta-ol,
- (S)-4-Methyl-3-((E)-2-((1R,3aR,7aR)-7a-methyl-1-((R)-6-methylheptan-2-yl)-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl)vinyl)cyclohex-3-enol
- (3|A,6E)-9,10-Secocholesta-5(10),6,8-trien-3-ol
- 1173-13-3
- 9,10-SECOCHOLESTA-5(10),6,8-TRIEN-3-OL, (3.BETA.,6E)-
- (1S)-3-[(1E)-2-[(1R,3aR,7aR)-1-[(1R)-1,5-Dimethylhexyl]-2,3,3a,6,7,7a-hexahydro-7a-methyl-1H-inden-4-yl]ethenyl]-4-methyl-3-cyclohexen-1-ol
- (1S)-3-[(1E)-2-[(1R,3aR,7aR)-1-[(1R)-1,5-dimethylhexyl]-2,3,3a,6,7,7a-hexahydro-7a-methyl-1H-inden-4-yl]ethenyl]-4-methyl-3-cyclohexen-1-ol; 9,10-Secocholesta-5(10),6,8-trien-3-ol, (3ss,6E)- (9CI); Tachysterol3 (6CI,7CI,8CI)
- (1S)-3-[(1E)-2-[(1R,3aR,7aR)-7a-methyl-1-[(2R)-6-methylheptan-2-yl]-2,3,3a,6,7,7a-hexahydro-1H-inden-4-yl]ethenyl]-4-methylcyclohex-3-en-1-ol
- (1S)-3-[(E)-2-[(1R,3aR,7aR)-1-[(1R)-1,5-dimethylhexyl]-7a-methyl-1,2,3,3a,6,7-hexahydroinden-4-yl]vinyl]-4-methyl-cyclohex-3-en-1-ol
- 241-561-3
- 3-CYCLOHEXEN-1-OL, 3-((1E)-2-((1R,3AR,7AR)-1-((1R)-1,5-DIMETHYLHEXYL)-2,3,3A,6,7,7A-HEXAHYDRO-7A-METHYL-1H-INDEN-4-YL)ETHENYL)-4-METHYL-, (1S)-
- N/A